- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Microbiome Therapeutics
Microbiome Therapeutics is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Biomarkers
- Microbiome Services Examine the community of commensal, symbiotic, and pathogenic microorganisms that make up the microbiome.
Testing Services
- Microbiological Sterility Testing Test the presence of viable microorganisms.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
MicroBiome Therapeutics’ focus is on products that modify the GI microbiota and its environment in specific ways to produce measureable improvements in health status. Our microbiome modulators act on multiple factors in the GI environment. In contrast to probiotics, which attempt to affect the GI microbiome by adding certain bacteria, our microbiome modulators take a comprehensive approach. They provide specialized nutrition that augments the growth of targeted desirable bacteria strains, and also modify factors such as the endocrine response that affects appetite, metabolism and energy...
Show the full description
MicroBiome Therapeutics’ focus is on products that modify the GI microbiota and its environment in specific ways to produce measureable improvements in health status.
Our microbiome modulators act on multiple factors in the GI environment. In contrast to probiotics, which attempt to affect the GI microbiome by adding certain bacteria, our microbiome modulators take a comprehensive approach. They provide specialized nutrition that augments the growth of targeted desirable bacteria strains, and also modify factors such as the endocrine response that affects appetite, metabolism and energy storage, providing an optimal GI environment conducive for health.
Our lead microbiome modulator, NM504, is currently being tested in a clinical trial for the management of insulin sensitivity and blood glucose levels in individuals with prediabetes and diabetes, as well as in a pilot clinical study as an adjunctive therapy to metformin, the most widely prescribed therapy worldwide for the management of type 2 diabetes.
- Website
- www.mbiome.com
Work with Microbiome Therapeutics on Scientist.com
For prices, more details, or to contact Microbiome Therapeutics, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.